Argenx Se (ARGX) Cash & Current Investments (2015 - 2026)
Argenx Se's Cash & Current Investments came in at $5.18 billion for Q2 2026, up 70.8% from $3.04 billion a year earlier.
Powered by 
Analysis
Argenx Se (ARGX) Cash & Current Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, Argenx Se's Cash & Current Investments was $4.44 billion, up 31.4% from FY2024.
- Cash & Current Investments has increased in each of the last three years, with a five-year compound annual growth rate of 17.3% (FY2020 to FY2025).
- Going back by year, Cash & Current Investments was $3.38 billion in FY2024 (+6.3%), $3.18 billion in FY2023 (+45.0%), $2.19 billion in FY2022 (-6.2%) and $2.34 billion in FY2021 (+16.8%).
- The Q2 2026 figure represents the highest quarterly Cash & Current Investments in data going back to Q4 2015.
- Year-over-year, Cash & Current Investments increased in three of the last four quarters, with growth averaging 25.0%.
- The fastest year-over-year change in Cash & Current Investments over five years came in Q2 2026 (growth of 70.8%), and the weakest in Q2 2023 (a decline of 23.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Argenx Se | 56.96 Bn | 56.96 Bn | 1.56 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.18 Bn |
| Dec 31, 2025 | 4.44 Bn |
| Jun 30, 2025 | 3.04 Bn |
| Dec 31, 2024 | 3.38 Bn |
| Jun 30, 2024 | 3.32 Bn |
| Dec 31, 2023 | 3.18 Bn |
| Jun 30, 2023 | 2.00 Bn |
| Dec 31, 2022 | 2.19 Bn |
| Jun 30, 2022 | 2.60 Bn |
| Dec 31, 2021 | 2.34 Bn |
| Jun 30, 2021 | 2.73 Bn |
| Dec 31, 2020 | 2.00 Bn |
| Jun 30, 2020 | 2.17 Bn |
| Dec 31, 2019 | 1.50 Bn |
| Jun 30, 2019 | 1.07 Bn |
| Dec 31, 2018 | 645.86 Mn |
| Jun 30, 2018 | 391.81 Mn |
| Dec 31, 2017 | 429.63 Mn |
| Jun 30, 2017 | 198.43 Mn |
| Dec 31, 2016 | 102.29 Mn |
API Access
Argenx Se Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();